Dunga S - Search Results

1

Effect of skin phototype on quantitative nailfold capillaroscopy.

Bairwa D, Kavadichanda CG, Dunga S, Mathew A, G A, M S G, Mamatha G, Thabah MM, Negi VS. Bairwa D, et al. Among authors: dunga s. J Scleroderma Relat Disord. 2022 Oct;7(3):197-203. doi: 10.1177/23971983221102688. Epub 2022 Jun 5. J Scleroderma Relat Disord. 2022. PMID: 36211202 Free PMC article.

2

Tele-rheumatology for overcoming socioeconomic barriers to healthcare in resource constrained settings: lessons from COVID-19 pandemic.

Kavadichanda C, Shah S, Daber A, Bairwa D, Mathew A, Dunga S, Das AC, Gopal A, Ravi K, Kar SS, Negi VS. Kavadichanda C, et al. Among authors: dunga s. Rheumatology (Oxford). 2021 Jul 1;60(7):3369-3379. doi: 10.1093/rheumatology/keaa791. Rheumatology (Oxford). 2021. PMID: 33284974 Free PMC article.

3

Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study.

Dunga SK, Kavadichanda C, Gupta L, Naveen R, Agarwal V, Negi VS. Dunga SK, et al. Rheumatol Int. 2022 Jul;42(7):1155-1165. doi: 10.1007/s00296-021-04897-1. Epub 2021 May 29. Rheumatol Int. 2022. PMID: 34050793

4

Performance of timed function tests as outcome measures in idiopathic inflammatory myopathy-results from a single-centre cohort.

Dunga S, Kavadichanda C, Bairwa D, Thabah MM, Negi VS. Dunga S, et al. Rheumatology (Oxford). 2022 Dec 23;62(1):290-299. doi: 10.1093/rheumatology/keac244. Rheumatology (Oxford). 2022. PMID: 35416957

5

Semi-quantitative thigh magnetic resonance imaging scores in assessing disease activity and determining long-term clinical outcome in idiopathic inflammatory myopathies: a causal mediation analysis.

Gorijavolu M, Bairwa D, Ganapathy S, Dunga S, Gopal A, Ananthakrishnan R, Thabah MM, Negi VS, Kavadichanda CG. Gorijavolu M, et al. Among authors: dunga s. Rheumatology (Oxford). 2024 Jan 4;63(1):111-118. doi: 10.1093/rheumatology/kead174. Rheumatology (Oxford). 2024. PMID: 37079733

6

Unlocking the potential: exploring the impact of dolutegravir treatment on body mass index improvement in underweight adults with HIV in Malawi.

Maphosa T, Dunga S, Makonokaya L, Woelk G, Maida A, Wang A, Ahimbisibwe A, Chamanga RK, Zimba SB, Kayira D, Machekano R. Maphosa T, et al. Among authors: dunga s. BMC Public Health. 2024 May 16;24(1):1321. doi: 10.1186/s12889-024-18818-x. BMC Public Health. 2024. PMID: 38755632 Free PMC article.

7

Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi.

Makonokaya L, Maida A, Kalitera LU, Wang A, Kapanda L, Kayira D, Bottoman M, Nkhoma H, Dunga S, Joaki Z, Chamanga R, Nkanaunena K, Hrapcak S, Nyirenda R, Chiwandira B, Maulidi M, Woelk G, Machekano R, Maphosa T. Makonokaya L, et al. Among authors: dunga s. AIDS Behav. 2024 Jun;28(6):2148-2155. doi: 10.1007/s10461-024-04312-3. Epub 2024 Apr 13. AIDS Behav. 2024. PMID: 38615099 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters